Targeted Therapy for Lung Cancer Using Bombesin Analogue
Author Information
Author(s): Kiaris H, Schally A V, Nagy A, Sun B, Armatis P, Szepeshazi K
Primary Institution: Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center
Hypothesis
Can a cytotoxic bombesin analogue effectively target and inhibit the growth of H-69 small-cell lung carcinoma cells?
Conclusion
The cytotoxic bombesin analogue AN-215 significantly inhibited the growth of H-69 small-cell lung carcinoma tumors in mice.
Supporting Evidence
- The bombesin analogue AN-215 showed strong antiproliferative effects on H-69 cells in vitro.
- In vivo, AN-215 significantly inhibited tumor growth compared to control groups.
- mRNA for bombesin receptor subtypes was detected in H-69 tumors.
Takeaway
Researchers created a special medicine that can help fight a type of lung cancer by targeting specific receptors on the cancer cells.
Methodology
H-69 cells were xenografted into nude mice, which were then treated with different compounds to evaluate tumor growth inhibition.
Potential Biases
Potential bias in the selection of treatment groups and the small sample size.
Limitations
The study was conducted in a small sample size of male nude mice, which may limit the generalizability of the results.
Participant Demographics
Male nude mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website